about
PPM1B negatively regulates antiviral response via dephosphorylating TBK1Salivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling.The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis.Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders.HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells.Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding.Vitamin d deficiency in a multiethnic healthy control cohort and altered immune response in vitamin D deficient European-American healthy controlsThe dysregulation of cytokine networks in systemic lupus erythematosus.Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7.Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity.Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosisAutoimmunity in picornavirus infections.Latest advances in connective tissue disorders.Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function.Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis.Interferon alpha 2b in the treatment of uveitic cystoid macular edema.Activation and regulation of interferon-β in immune responses.Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.The Regulation of Immune Responses by DC Derived Type I IFN.Antiphospholipid antibodies mediate autoimmunity against dying cells.Aberrant B cell selection and activation in systemic lupus erythematosus.Bacterial E3 Ubiquitin Ligase IpaH4.5 of Shigella flexneri Targets TBK1 To Dampen the Host Antibacterial Response.Expression and functionality of type I interferon receptor in the megakaryocytic lineage.Reverse transcription real-time PCR for detection of porcine interferon α and β genes.Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis.Carbon monoxide inhibits T cell activation in target organs during systemic lupus erythematosus.The Extracellular IFI16 Protein Propagates Inflammation in Endothelial Cells Via p38 MAPK and NF-κB p65 Activation.A synthetic TLR3 ligand mitigates profibrotic fibroblast responses by inducing autocrine IFN signaling.A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice.T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis.Distinctive expression of T cell guiding molecules in human autoimmune lymph node stromal cells upon TLR3 triggering.Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus.Editorial: "Interfering" with preeclampsia.Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus.Using human demographic history to infer natural selection reveals contrasting patterns on different families of immune genes.Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese
P2860
Q24339402-C1F8FDF7-9C56-47F1-8F99-EC77E6DAF3FCQ30415532-0FF95EF4-32C0-4A95-8FB5-E68FC0FD9CF3Q34571170-1EAC0F9A-E3C1-4C08-B0F8-AA4A07837788Q34689823-05188D91-E25E-4065-A548-4ECE8F216310Q34707327-2F310A61-3D39-4611-838E-FAEEC00ACE70Q34729999-19A493D0-D264-4A62-9029-8AAFAD1F6D69Q35146600-D8FEE90D-4BF5-47BE-BCB0-08ED4E7A3B98Q35294513-EF288CF7-44B5-4EC9-A8EC-73ABCFF1DDEEQ35402128-3BC17077-4F07-4FCE-A904-C4E10B40560DQ35685720-B2625D37-AC0C-47EF-90A7-A73356584A35Q36014384-F27A18E9-5CBE-49B7-ABD5-E96B30F8D5D4Q36767670-C7554BF9-1D8F-4E17-82FF-98519C52DC3BQ37058776-2A6BDFDB-D060-4058-AD0F-262526233878Q37224572-C592F290-CC29-436E-BAFC-F1E819906957Q37331952-0E8E7615-966C-4417-BB7E-046A3B835392Q37992704-5DE760DD-5474-4299-846B-9911B6360BCAQ37992879-ECB57DBA-5158-4692-A1D3-3F7D0C837E94Q38093766-E8183DBF-7DFF-44C6-9D26-056C271C21E0Q38102693-7C333E3A-05CB-4BE0-A3CB-6EE200883CEEQ38109906-FD7C82A9-9858-4C81-9A18-AE8DA12A1C80Q38114501-97A1B8C8-09CB-44FE-BF6C-BAC63537F38CQ38809321-A59CB9F6-8777-4CEE-B9D5-118C7E38339CQ39434066-6C559585-4228-495A-9C0D-986C60BE2063Q39529990-5CCAA496-09FB-456F-B594-B0EAB1478788Q40597789-BB85961F-9A14-4100-BC86-FDB513F06A1AQ40815460-3723F512-732A-4C0E-A6FD-7038346D095BQ41350185-458707C7-DDFB-4179-B973-928812E39022Q41851717-D505B5CA-C684-4C9B-8494-5BCD53A57212Q44175614-0183B6E5-D879-462A-80CE-A6A55C1B1668Q47367610-A4BAE556-1309-4667-9326-604D3B1278F7Q47548140-3B779E1A-E47F-4CF0-BEB0-328A0ACD1CDDQ51047575-4598D3FC-4A4C-4949-9D18-3D9DA9CE67B2Q54295685-363BC38E-6BA8-4DEA-9885-3907FCB24289Q55100613-3E851155-98DF-403B-960B-0B2A239434F4Q55255783-72FD5B3B-CC21-46DB-BD31-2DB60C5E0BCCQ58694999-1F2FD1DE-BCE0-412D-A20A-E764977EFBFF
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Type I interferons in systemic autoimmunity.
@en
Type I interferons in systemic autoimmunity.
@nl
type
label
Type I interferons in systemic autoimmunity.
@en
Type I interferons in systemic autoimmunity.
@nl
prefLabel
Type I interferons in systemic autoimmunity.
@en
Type I interferons in systemic autoimmunity.
@nl
P2093
P2860
P1433
P1476
Type I interferons in systemic autoimmunity.
@en
P2093
Daniela Bosisio
Mirko Scarsi
Silvano Sozzani
P2860
P304
P356
10.3109/08916930903510872
P577
2010-04-01T00:00:00Z